Cargando…
Effectiveness of Breast MRI and (18)F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma
PURPOSE: We evaluated the utility of magnetic resonance imaging (MRI) and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) for the preoperative staging of invasive lobular carcinoma (ILC) of the breast and compared the results with those of invasive ductal...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381125/ https://www.ncbi.nlm.nih.gov/pubmed/25834613 http://dx.doi.org/10.4048/jbc.2015.18.1.63 |
_version_ | 1782364403569524736 |
---|---|
author | Jung, Na Young Kim, Sung Hoon Kim, Sung Hun Seo, Ye Young Oh, Jin Kyoung Choi, Hyun Su You, Won Jong |
author_facet | Jung, Na Young Kim, Sung Hoon Kim, Sung Hun Seo, Ye Young Oh, Jin Kyoung Choi, Hyun Su You, Won Jong |
author_sort | Jung, Na Young |
collection | PubMed |
description | PURPOSE: We evaluated the utility of magnetic resonance imaging (MRI) and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) for the preoperative staging of invasive lobular carcinoma (ILC) of the breast and compared the results with those of invasive ductal carcinoma (IDC). METHODS: The study included pathologically proven 32 ILCs and 73 IDCs. We compared clinical and histopathological characteristics and the diagnostic performances of MRI and (18)F-FDG PET/CT for the primary mass, additional ipsilateral and/or contralateral lesion(s), and axillary lymph node metastasis between the ILC and IDC groups. RESULTS: Primary ILCs were greater in size, but demonstrated lower maximum standardized uptake values than IDCs. All primary masses were detected on MRI. The detection rate for ILCs (75.0%) was lower than that for IDCs (83.6%) on (18)F-FDG PET/CT, but the difference was not significant. For additional ipsilateral lesion(s), the sensitivities and specificities of MRI were 87.5% and 58.3% for ILC and 100.0% and 66.7% for IDC, respectively; whereas the sensitivities and specificities of (18)F-FDG PET/CT were 0% and 91.7% for ILC and 37.5% and 94.7% for IDC, respectively. The sensitivity of (18)F-FDG PET/CT for ipsilateral lesion(s) was significantly lower in the ILC group than the IDC group. The sensitivity for ipsilateral lesion(s) was significantly higher with MRI; however, specificity was higher with (18)F-FDG PET/CT in both tumor groups. There was no significant difference in the diagnostic performance for additional contralateral lesion(s) or axillary lymph node metastasis on MRI or (18)F-FDG PET/CT for ILC versus IDC. CONCLUSION: The MRI and (18)F-FDG PET/CT detection rates for the primary cancer do not differ between the ILC and IDC groups. Although (18)F-FDG PET/CT demonstrates lower sensitivity for primary and additional ipsilateral lesions, it shows higher specificity for additional ipsilateral lesions, and could play a complementary role in the staging of ILC as well as IDC. |
format | Online Article Text |
id | pubmed-4381125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Korean Breast Cancer Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-43811252015-04-01 Effectiveness of Breast MRI and (18)F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma Jung, Na Young Kim, Sung Hoon Kim, Sung Hun Seo, Ye Young Oh, Jin Kyoung Choi, Hyun Su You, Won Jong J Breast Cancer Original Article PURPOSE: We evaluated the utility of magnetic resonance imaging (MRI) and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) for the preoperative staging of invasive lobular carcinoma (ILC) of the breast and compared the results with those of invasive ductal carcinoma (IDC). METHODS: The study included pathologically proven 32 ILCs and 73 IDCs. We compared clinical and histopathological characteristics and the diagnostic performances of MRI and (18)F-FDG PET/CT for the primary mass, additional ipsilateral and/or contralateral lesion(s), and axillary lymph node metastasis between the ILC and IDC groups. RESULTS: Primary ILCs were greater in size, but demonstrated lower maximum standardized uptake values than IDCs. All primary masses were detected on MRI. The detection rate for ILCs (75.0%) was lower than that for IDCs (83.6%) on (18)F-FDG PET/CT, but the difference was not significant. For additional ipsilateral lesion(s), the sensitivities and specificities of MRI were 87.5% and 58.3% for ILC and 100.0% and 66.7% for IDC, respectively; whereas the sensitivities and specificities of (18)F-FDG PET/CT were 0% and 91.7% for ILC and 37.5% and 94.7% for IDC, respectively. The sensitivity of (18)F-FDG PET/CT for ipsilateral lesion(s) was significantly lower in the ILC group than the IDC group. The sensitivity for ipsilateral lesion(s) was significantly higher with MRI; however, specificity was higher with (18)F-FDG PET/CT in both tumor groups. There was no significant difference in the diagnostic performance for additional contralateral lesion(s) or axillary lymph node metastasis on MRI or (18)F-FDG PET/CT for ILC versus IDC. CONCLUSION: The MRI and (18)F-FDG PET/CT detection rates for the primary cancer do not differ between the ILC and IDC groups. Although (18)F-FDG PET/CT demonstrates lower sensitivity for primary and additional ipsilateral lesions, it shows higher specificity for additional ipsilateral lesions, and could play a complementary role in the staging of ILC as well as IDC. Korean Breast Cancer Society 2015-03 2015-03-27 /pmc/articles/PMC4381125/ /pubmed/25834613 http://dx.doi.org/10.4048/jbc.2015.18.1.63 Text en © 2015 Korean Breast Cancer Society. All rights reserved. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Jung, Na Young Kim, Sung Hoon Kim, Sung Hun Seo, Ye Young Oh, Jin Kyoung Choi, Hyun Su You, Won Jong Effectiveness of Breast MRI and (18)F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma |
title | Effectiveness of Breast MRI and (18)F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma |
title_full | Effectiveness of Breast MRI and (18)F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma |
title_fullStr | Effectiveness of Breast MRI and (18)F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma |
title_full_unstemmed | Effectiveness of Breast MRI and (18)F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma |
title_short | Effectiveness of Breast MRI and (18)F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma |
title_sort | effectiveness of breast mri and (18)f-fdg pet/ct for the preoperative staging of invasive lobular carcinoma versus ductal carcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381125/ https://www.ncbi.nlm.nih.gov/pubmed/25834613 http://dx.doi.org/10.4048/jbc.2015.18.1.63 |
work_keys_str_mv | AT jungnayoung effectivenessofbreastmriand18ffdgpetctforthepreoperativestagingofinvasivelobularcarcinomaversusductalcarcinoma AT kimsunghoon effectivenessofbreastmriand18ffdgpetctforthepreoperativestagingofinvasivelobularcarcinomaversusductalcarcinoma AT kimsunghun effectivenessofbreastmriand18ffdgpetctforthepreoperativestagingofinvasivelobularcarcinomaversusductalcarcinoma AT seoyeyoung effectivenessofbreastmriand18ffdgpetctforthepreoperativestagingofinvasivelobularcarcinomaversusductalcarcinoma AT ohjinkyoung effectivenessofbreastmriand18ffdgpetctforthepreoperativestagingofinvasivelobularcarcinomaversusductalcarcinoma AT choihyunsu effectivenessofbreastmriand18ffdgpetctforthepreoperativestagingofinvasivelobularcarcinomaversusductalcarcinoma AT youwonjong effectivenessofbreastmriand18ffdgpetctforthepreoperativestagingofinvasivelobularcarcinomaversusductalcarcinoma |